Neural Therapeutics, Inc. (NURL.CX)

0.015 0.00 (0.00%) CAD  |  CNSX  |  Apr 01, 16:00
More

Neural Therapeutics Revenue Estimates for Current Fiscal Year

Revenue Estimates for Current Fiscal Year Chart

View Revenue Estimates for Current Fiscal Year for NURL.CX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Revenue Estimates for Current Fiscal Year Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Revenue Estimates for Current Fiscal Year Range, Past 5 Years

View Revenue Estimates for Current Fiscal Year Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue Estimates for Current Fiscal Year Benchmarks

View Revenue Estimates for Current Fiscal Year Benchmarks
Start Trial
BioMark Diagnostics, Inc. --
Justera Health Ltd. --
Wesana Health Holdings, Inc. Upgrade
Arch Biopartners, Inc. Upgrade
Biocure Technology, Inc. --